Arkolith/Insider Trading/TNGX/Form 4

Weber Barbara

Chief Executive Officer, DirectorTango Therapeutics, Inc. (TNGX) · full profile →Form 4 · filed Feb 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$58K
Net Open-Market Flow
-$58K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 5, 2025Sell(S)9K$3.16$28K1.6M
Feb 4, 2025Sell(S)10K$2.99$29K1.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-015684) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML